Ashit Trivedi Selected Research

Apelin Receptors

6/2022	Evaluation of the Pharmacokinetics and Safety of AMG 986 Tablet and Capsule Formulations in Healthy Adult Subjects: A Phase I, Open-Label, Randomized Study.
6/2022	A Phase I, Open-label, Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of AMG 986 in Healthy Japanese Subjects.
4/2022	A First-in-Human Study of AMG 986, a Novel Apelin Receptor Agonist, in Healthy Subjects and Heart Failure Patients.
3/2022	Effect of Severe Renal Impairment on the Safety, Tolerability, and Pharmacokinetics of AMG 986.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ashit Trivedi Research Topics

Disease

18	Heart Failure 06/2022 - 01/2021
4	Tuberculosis (Tuberculoses) 01/2019 - 10/2012
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2021
1	Infections 01/2018
1	Extensively Drug-Resistant Tuberculosis 02/2014

Drug/Important Bio-Agent (IBA)

13	omecamtiv mecarbilIBA 01/2022 - 01/2021
12	Cardiac MyosinsIBA 01/2022 - 01/2021
4	Apelin ReceptorsIBA 06/2022 - 03/2022
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 02/2014
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022
1	TabletsIBA 01/2022
1	Cytochrome P-450 CYP3AIBA 01/2022
1	Rosuvastatin Calcium (Crestor)FDA Link 11/2021
1	CytokinesIBA 01/2018
1	Pharmaceutical PreparationsIBA 02/2014
1	Bacterial Proteins (Bacterial Protein)IBA 02/2014
1	Spectinomycin (Spectinomycin Hydrochloride)FDA Link 02/2014
1	Antitubercular AgentsIBA 10/2012

Therapy/Procedure

1	Drug Tapering 01/2022
1	Drug Therapy (Chemotherapy) 01/2018
1	Therapeutics 02/2014